Adenovirus-based cancer gene therapy

Area of Science:

• Oncology
• Gene Therapy
• Virology

Background:

• Adenovirus (Ad)-based vectors are widely utilized in cancer gene therapy.
• Two primary strategies involve direct tumor cell killing and immunotherapy.
• Both strategies aim for selective tumor destruction with minimal normal tissue damage.

Purpose of the Study:

• To review Ad-based cancer gene therapy approaches.
• To discuss recent advancements and progress in the field.
• To highlight challenges and potential solutions for Ad vector efficacy.

Main Methods:

• Review of pre-clinical and clinical studies on Ad-based cancer gene therapy.
• Analysis of strategies for direct tumor cell killing (oncolytic viruses, gene delivery).
• Evaluation of immunotherapeutic approaches using Ad vectors.

Main Results:

• Encouraging results have been observed in pre-clinical and clinical studies.
• Robust clinical efficacy remains a challenge.
• Key obstacles include inefficient tumor cell transduction and host anti-Ad immune responses.

Conclusions:

• Continued advancements in Ad and tumor biology are leading to sophisticated approaches.
• Overcoming transduction efficiency and immune response limitations is crucial for therapeutic success.
• Further research is needed to translate promising Ad-based strategies into effective clinical treatments.